Free Trial
NASDAQ:PRE

Prenetics Global Q2 2025 Earnings Results & Report

Prenetics Global logo
$16.63 -0.09 (-0.54%)
As of 11:42 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Prenetics Global reported Q2 2025 earnings on September 12, 2025. The company reported EPS of -$0.82, while revenue was $17.68 million.

Earnings Announcement Details

Quarter
Q2 2025
Time
Before Market Opens

Prenetics Global EPS Results

Actual EPS
-$0.82
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A
EPS Beat Rate
5 of last 6 quarters

Prenetics Global Revenue Results

Actual Revenue
$17.68 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Upcoming Earnings

Prenetics Global's Q3 2026 earnings is estimated for Wednesday, November 18, 2026, based on past reporting schedules, with a conference call scheduled at 8:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Conference Call Resources

Prenetics Global Q2 2025 Earnings FAQ

Prenetics Global (NASDAQ:PRE) reported earnings of -$0.82 per share for Q2 2025. The report was announced on Friday, September 12, 2025.

Prenetics Global reported revenue of $17.68 million for Q2 2025.

Prenetics Global's next earnings date is estimated for Wednesday, November 18, 2026. MarketBeat tracks confirmed and estimated earnings dates for Prenetics Global on the company's earnings history page.

Prenetics Global Earnings Headlines

PRE Announces Strategic Partnership
Trump compared today's market to 1929
President Trump warned of a 1929-style depression if Democrats won control of Congress. On November 3, they did. Before a single vote was counted, the IMF flagged markets as increasingly exposed to a sharp correction, Ray Dalio called conditions a classic bubble, and Peter Schiff said a downturn could hit regardless of the outcome.tc pixel
Prenetics Global Names Brian Rosin to Succeed Stephen Lo as CFO
See More Prenetics Global Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Prenetics Global? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Prenetics Global and other key companies, straight to your email.

About Prenetics Global

Prenetics Global (NASDAQ:PRE) is a health sciences company focused on consumer wellness and health-related products. Its portfolio includes IM8, a consumer wellness brand offering nutritional supplements, and CircleDNA, a genetic testing service that provides reports on health, wellness and ancestry.

The company has also operated clinical genomic testing services and provided COVID-19 testing during the pandemic. Its business has since shifted toward consumer health and wellness.

Prenetics was founded in 2014 and is led by co-founder and Chief Executive Officer Danny Yeung. The company has roots in Hong Kong and has served customers in multiple markets through its testing and consumer health businesses.

View Prenetics Global Profile